Shiraz E-Medical Journal

Published by: Kowsar
Crossmark

Serum and 24-Hour Urinary Uric Acid Levels in Patients with Urolithiasis

Mohammad Yazdani 1 , Amid Yazdani 2 , Kourosh Noori-Mahdavi 1 , Mahmoud Kabiri 1 , Shahzad Baradaran 3 and Hamid Nasri 4 , *
Authors Information
1 Department of Urology, Isfahan University of Medical sciences, Isfahan, IR Iran
2 Faculty of Medicine, Isfahan University of Medical sciences, Isfahan, IR Iran
3 Department of Pathology, Jahad Daneshgahi, University of Isfahan, Isfahan, IR Iran
4 Department of Nephrology, Isfahan University of Medical sciences, Isfahan, IR
Article information
  • Shiraz E-Medical Journal: February 01, 2015, 16 (2); e26470
  • Published Online: February 20, 2015
  • Article Type: Research Article
  • Received: December 11, 2014
  • Accepted: December 30, 2014
  • DOI: 10.17795/semj26470

To Cite: Yazdani M, Yazdani A, Noori-Mahdavi K, Kabiri M, Baradaran S, et al. Serum and 24-Hour Urinary Uric Acid Levels in Patients with Urolithiasis, Shiraz E-Med J. 2015 ; 16(2):e26470. doi: 10.17795/semj26470.

Abstract
Copyright © 2015, Shiraz University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Materials and Methods
4. Results
5. Discussion
Footnote
References
  • 1. Gyawali PR, Joshi BR, Gurung CK. Correlation of calcium, phosphorus, uric acid and magnesium level in serum and 24 hours urine of patients with urolithiasis. Kathmandu Univ Med J (KUMJ). 2011; 9(34): 54-6[PubMed]
  • 2. Nematbakhsh M, Nasri H. The effects of vitamin E and selenium on cisplatin-induced nephrotoxicity in cancer patients treated with cisplatin-based chemotherapy: A randomized, placebo-controlled study. J Res Med Sci. 2013; 18(7): 626-7[PubMed]
  • 3. Nasri H. Antioxidants for prevention of gentamicin-induced nephrotoxicity. Iran J Kidney Dis. 2014; 8(1): 1-2[PubMed]
  • 4. Amiri M, Nasri H. Secondary Hyperparathyroidism in chronic kidney disease patients; current knowledge. J Parathyr Dis. 2014; 2(1): 1-3
  • 5. Hajivandi A, Amiri M. World kidney day 2014: Kidney disease and elderly. J Parathyr Dis. 2014; 2(1): 5-6
  • 6. Moe OW. Kidney stones: pathophysiology and medical management. Lancet. 2006; 367(9507): 333-44[DOI][PubMed]
  • 7. Nasri H, Rafieian-Kopaei M. Oxidative stress and aging prevention. Int J Prev Med. 2013; 4(9): 1101-2[PubMed]
  • 8. Pak CY, Resnick MI, Preminger GM. Ethnic and geographic diversity of stone disease. Urology. 1997; 50(4): 504-7[PubMed]
  • 9. Nasri H. Re: effect of silymarin on streptozotocin-nicotinamide-induced type 2 diabetic nephropathy in rats. Iran J Kidney Dis. 2013; 7(5): 414-5[PubMed]
  • 10. Gheissari A, Hemmatzadeh S, Merrikhi A, Fadaei Tehrani S, Madihi Y. Chronic kidney disease in children: A report from a tertiary care center over 11 years. J Nephropathol. 2012; 1(3): 177-82[DOI][PubMed]
  • 11. Amiri M, Nasri H. Secondary Hyperparathyroidism in chronic kidney disease patients; current knowledge. J Parathyr Dis. 2014; 2(1): 1-2
  • 12. Baradaran A. Primary hyperparathyroidism and kidney; recent findings. J Parathyr Dis. 2014; 2(1): 7-10
  • 13. Taylor EN, Stampfer MJ, Curhan GC. Dietary factors and the risk of incident kidney stones in men: new insights after 14 years of follow-up. J Am Soc Nephrol. 2004; 15(12): 3225-32[DOI][PubMed]
  • 14. Ramello A, Vitale C, Marangella M. Epidemiology of nephrolithiasis. J nephrol. 1999; 13: 45-50
  • 15. Nasri H. Elevated serum parathyroid hormone is a heart risk factor in hemodialysis patients. J Parathyr Dis. 2014; 1(1): 13-6
  • 16. Kari J. Epidemiology of chronic kidney disease in children. J Nephropathol. 2012; 1(3): 162-3[DOI][PubMed]
  • 17. Nasri H. Comment on: A model for prediction of cisplatin induced nephrotoxicity by kidney weight in experimental rats. J Res Med Sci. 2013; 18(12): 1119-20[PubMed]
  • 18. Nasri H. Impact of diabetes mellitus on parathyroid hormone in hemodialysis patients. J Parathyr Dis. 2014; 1(1): 9-11
  • 19. Silva SF, Silva SL, Campos Hde H, Daher Ede F, Silva CA. [Demographic, clinical and laboratory data of patients with urinary lithiasis in Fortaleza, Ceara]. J Bras Nefrol. 2011; 33(3): 295-9[PubMed]
  • 20. Ardalan M-R, Nasri H. Acute kidney injury; the focus of world kidney day in 2013. J Nephropharmacol. 2015; 2(2): 15-6
  • 21. Yamaguchi S. [Relationship between metabolic syndrome and urinary stone disease]. Clin Calcium. 2011; 21(10): 1489-95[PubMed]
  • 22. Nasri H, Rafieian-Kopaei M. Significant difference of serum 25-hydroxyvitamin D level in male hemodialysis patients with or without diabetes; a single center study. J Nephropharmacol. 2015; 1(2): 15-6
  • 23. Nasri H, Nematbakhsh M, Rafieian-Kopaei M. Ethanolic extract of garlic for attenuation of gentamicin-induced nephrotoxicity in Wistar rats. Iran J Kidney Dis. 2013; 7(5): 376-82[PubMed]
  • 24. Baradaran A, Nasri H, Rafieian-Kopaei M. Comment on: Anti-Oxidative Stress Activity of Stachys lavandulifolia Aqueous Extract in Humans. Cell J. 2013; 15(3): 272-3[PubMed]
  • 25. Nasri H, Rafieian-Kopaei M. Association of serum vitamin D level with age in individuals with normal renal function. J Nephropharmacol. 2015; 1(1): 7-9
  • 26. Kanamaru H, Sasaki M, Ohshiro K, Komatz Y. [A clinical study of urolithiasis in Shizuoka City Hospital--stone analysis and 24-hour urine calcium and uric acid levels]. Hinyokika Kiyo. 1985; 31(6): 915-20[PubMed]
  • 27. Gheissari A, Rezaii Z, Merrikhi A, Madihi Y, Kelishadi R. Association of neutrophil gelatinase associated lipocalin and cystatin-C with kidney function in children with nephrotic syndrome. Int J Prev Med. 2013; 4(8): 956-63[PubMed]
  • 28. Moussavi H-R. Osteoporosis in chronic kidney disease; a mini-review on current knowledge. J Parathyr Dis. 2014; 1(1): 5-8
  • 29. Nasri H. Correlation of serum magnesium with serum levels of 25-hydroxyvitamin D in hemodialysis patients. J Parathyr Dis. 2014; 2(1): 11-3
  • 30. Nasri H, Rafieian-Kopaei M. Parathyroid hormone in renal transplanted recipients; a single center study. J Nephropharmacol. 2015; 2(1): 3-4
  • 31. Freitas Junior CH, Mazzucchi E, Danilovic A, Brito AH, Srougi M. Metabolic assessment of elderly men with urolithiasis. Clinics (Sao Paulo). 2012; 67(5): 457-61[PubMed]
  • 32. Spasovski D. Renal markers for assessment of renal tubular and glomerular dysfunction. J Nephropharmacol. 2015; 2(2): 23-5
  • 33. Tavafi M. Complexity of diabetic nephropathy pathogenesis and design of investigations. J Renal Inj Prev. 2013; 2(2): 59-62[DOI][PubMed]
  • 34. Milosevic D, Batinic D, Konjevoda P, Blau N, Stambuk N, Nizic L, et al. Analysis of calcium, oxalate, and citrate interaction in idiopathic calcium urolithiasis in children. J Chem Inf Comput Sci. 2003; 43(6): 1844-7[DOI][PubMed]
  • 35. Abe T, Akakura K, Kawaguchi M, Ueda T, Ichikawa T, Ito H, et al. Outcomes of shockwave lithotripsy for upper urinary-tract stones: a large-scale study at a single institution. J Endourol. 2005; 19(7): 768-73[DOI][PubMed]
  • 36. Albala DM, Assimos DG, Clayman RV, Denstedt JD, Grasso M, Gutierrez-Aceves J, et al. Lower pole I: a prospective randomized trial of extracorporeal shock wave lithotripsy and percutaneous nephrostolithotomy for lower pole nephrolithiasis-initial results. J Urol. 2001; 166(6): 2072-80[PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments